Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
30.03.23
/
50%
€89.90
Target price
30.03.24
€120.95
Performance (%)
47.22%
End price
01.04.24
€132.35
Summary
This prediction ended on 01.04.24 with a price of €132.35. The BUY prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience saw massive gains of 47.22%. Canaccord_Genuity_Gr has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neurocrine Bioscience | 13.485% | 13.485% | 18.494% | 44.231% |
| iShares Core DAX® | 0,42 % | 5,71 % | 4,70 % | 50,38 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % | 38,95 % | 104,42 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % | 50,39 % | 74,97 % |
| iShares S&P 500 | 1,79 % | 9,64 % | 26,90 % | 72,28 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $132.00 price target on the stock, up previously from $124.00.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.90
07.04.26
07.04.26
€173.46
07.04.27
07.04.27
12.93%
07.05.26
07.05.26
